



Objective: To assess the incidence of mood swings (MS) and possible associated factors 
in patients with Crohn’s disease (CD). Methods: Prospective longitudinal study of 50 
patients (60% females; mean age 40.6 years) with a diagnosis of CD over a 16-month fol-
low-up. Clinical activity was assessed by the CD activity index. Psychological status self-
report tools (Beck Depression Inventory and the anxiety subscale of the Hospital Anxi-
ety and Depression Scale) were used for mood disorder diagnosis. The tools were applied 
at baseline and at four-month intervals thereafter. Results: The inflammatory phenotype 
was the most common (86%); 36% had a previous history of surgery related to CD; 82% 
were in clinical remission at baseline. MS occurred in 58% of patients; 28% had progres-
sion of depression and/or anxiety symptoms from baseline normal mood, and 30% had 
baseline depressive and/or anxious mood normalized. In 38% of patients with MS, no 
change in the disease clinical activity could be found (p = 0.015), whereas 20% had a 
change in CD activity. Female gender and absence of previous surgery related to CD com-
plications were associated with higher MS incidence (p = 0.04 for both). Conclusion: In 
this study, a high MS incidence (58%) was found in patients with CD. Female gender and 
absence of previous surgery from CD complications were associated with a higher MS 
incidence. Periodic psychological assessment could be useful to detect and approach 
MS in patients with CD.
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INTRODUCTION
Crohn’s disease (CD) is a transmural inflammatory dis-
ease, incurable to date, that may affect the whole gastro-
intestinal tract, from the mouth to the anus. First de-
scribed by Gunzburg and Oppenheimer in 1932, it is an 
immune-mediated disease characterized by a remitting-
relapsing course1. As it a chronic disease, its impact on 
the quality of social, occupational, and family life may be 
significant2-4.
In North America, the annual incidence of CD ranges 
from 2.2 to 14.3 cases per 100,000 people, with prevalence 
rates being 26 to 210 cases per 100,000 people5,6. Despite 
the lower CD incidence in South America and Asia, sev-
eral studies have directed attention to the growing num-
ber of cases diagnosed worldwide7. In Brazil, one of the 
first studies reported was that by Gaburri et al., highlight-
ing the growing numbers of individuals diagnosed with 
CD in the second half of the 20th century8. These data 
were later confirmed by Souza et al.9.
CD etiology remains unknown. Inflammatory bowel 
diseases (IBDs) were once considered psychosomatic. 
Progress in biomedical understanding in the field of 
chronic illnesses has highlighted genetic, environmen-
tal, and molecular features in IBD pathogenesis10. On the 
other hand, the contributions of psychological factors on 
the disease course have been neglected11.
The current understanding of IBD multifactorial cau-
sality focuses on a possible disease process modulation by 
emotional states, which might aggravate symptoms, cause 
relapses or, on the contrary, positively influence the previ-
ous situation12-14. In this new setting, environmental, food, 
immune, and infectious factors have been exhaustively in-
vestigated as possible causes for CD. Currently, one of the 
most accepted theories is the immune. However, a strong 
indication of the impact of emotions on intestinal diseas-
es is observed both in CD and ulcerative colitis15.
Recently, a number of reports have approached the 
occurrence of psychological disorders affecting patients 
with CD, as well as possible interactions10,15. Although 
this association is currently well-accepted, there has been 
little change and impact on the disease course and clinical 
practice15,16. There is much controversy, and there are few 
prospective and controlled studies on the possible role 
that psychological aspects play in eliciting and/or influ-
encing clinical course of IBD.
The gastrointestinal tract is one of the most common 
sites affected by somatic symptoms precipitated by psy-
chological factors. The fact that depression symptoms can 
have a direct influence on immune disorders associated 
with CD17 and a negative effect on several chronic diseases 
is noted18. In addition, a great number of patients relate 
the occurrence of appetite loss, nausea, and diarrhea to an 
event generating anxiety19.
Determining the occurrence of mood swings and 
their possible association with patients’ and CD char-
acteristics may allow for the implementation of specific 
therapies targeting an identified psychological disorder, 
thus contributing to a better overall approach, which 
may improve the quality of life. However, few studies 
are reported in Brazil regarding CD, despite the grow-
ing interest in the topic. To date, there are no prospective 
longitudinal studies in Brazil assessing the occurrence of 
mood swings in patients with CD, as well as possible fac-
tors associated with the disease.
Considering the importance of the topic, the current 
study aims to assess the incidence of mood swings in pa-
tients with CD, as well as the possible associated factors.
METHODS
This is a prospective longitudinal study in which 55 pa-
tients with CD in regular follow-up at the outpatient IBD 
clinic of the Gastroenterology Department of the Uni-
versidade Federal de Juiz de Fora’s (UFJF) Hospital were 
consecutively included in a psychological assessment of 
their mood status. The assessment was conducted from 
August 2009 to December 2010.
The study was approved by the UFJF’s Ethics in Re-
search Committee and all subjects signed an informed 
consent containing information about the study objec-
tive and methods. The patients were assured the right not 
to participate in the study; nonparticipation would not 
interfere with their treatment in the facility.
CD diagnosis was established by combining clinical, 
endoscopic, and radiologic data supplemented by the 
typical histological aspect in either mucous membrane 
biopsies or surgery resection specimens when available20.
The following were considered exclusion criteria: (a) 
age < 18 years or > 65 years; (b) indication of hospital ad-
mission or immediate surgery resulting from CD compli-
cation; (c) fulminating disease; (d) presence of a stoma or 
short bowel syndrome; (e) current or previous diagnosis 
of psychosis; (f) pregnancy; (g) breastfeeding women; (h) 
lost to follow-up.
Demographics, such as gender, age, marital status, 
and education, were recorded at baseline. Medical his-
tory and clinical features related to CD were evaluated 
for: (a) CD location; (b) disease duration (in months); 
(c) clinical activity; (d) presence and site of fistulae; (e) 
medication use; (f) current history of alcohol intake and 
tobacco use; (g) prior surgery history if resulting from 
CD complication; (h) family history of depression. Alco-
hol intake was considered significant when higher than 
60 grams/day in males and 40 grams/day in females.
The Vienna classification was used to assess the 
phenotype of patients with CD21. Disease activity was 
assessed through the Crohn’s Disease Activity Index 
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(CDAI), which has been strictly developed and validat-
ed; a score < 150 points was considered “remitting dis-
ease” and a score ≥ 150 points was considered “disease 
activity”22.
In the presence of fistulae, a drainage evaluation was 
routinely performed in order to grade them as either 
“open and actively draining” or “closed”, as previously 
suggested23.
The assessment of CD activity was conducted by a 
physician unaware of the patient’s psychological status at 
the time of the application of questionnaires.
The psychological assessment was performed by a 
single professional (Flávia D’Agosto Vidal de Lima) at 
baseline and at four-month intervals thereafter over the 
12 subsequent months. The patients were requested to 
complete the psychological status self-report, the Beck 
Depression Inventory (BDI), and the seven-item anxiety 
subscale of the Hospital Anxiety and Depression Scale 
(HADS-A), aiming to identify depression or anxiety 
symptoms, respectively. The HADS-A has been previous-
ly used in patients with IBD24, showing good reliability 
and validity.
The BDI is a psychometric instrument of depression 
self-report widely used in several populations, translated 
into several languages, and validated in different coun-
tries, including Brazil25. The original scale contains 21 
items including symptoms and attitudes, with their se-
verity ranging from 0 to 3, aiming to identify the pres-
ence of depressive mood indicators, encompassing dif-
ferent symptom categories, such as: mood (sadness, loss 
of interest, crying, mood swings), vegetative or somatic 
(weight loss, loss of appetite, sleep loss, fatigue), cogni-
tive (guilt, hopelessness, suicidal ideation), social (social 
isolation, self-consciousness), and motor (inhibition, ex-
citement)26. Patients scoring > 20 were considered as hav-
ing a depressive mood in accordance with the Brazilian 
BDI validation25.
The HADS-A is a simple self-reported scale with 14 
multiple choice questions containing two subscales for 
anxiety and depression. In two wide literature reviews, 
the HADS showed appropriate screening properties for 
separate dimensions of anxiety and depression27. Patients 
scoring > 8 at HADS-A were considered as having anxi-
ety symptoms according to the national validation28.
Patients exhibiting a change in their psychological 
status in at least one follow-up visit were considered as 
having mood swings. Patients with a diagnosis of mood 
swings were assigned to psychological treatment accord-
ing to their indication.
At the psychological reassessment,  CD’s clinical 
activity was ascertained to establish any correlation 
between the two variables, as well as a temporal rela-
tionship. The comparison between groups, as well as a 
possible relationship between socio-demographic and 
clinical data and mood swings, was analyzed by using 
Student’s t-test and the chi-squared test or the Mann-
Whitney test as appropriate. The possible correlation 
between mood swings and CD clinical activity was as-
sessed by t-tests for paired samples. A p-value < 0.05 was 
considered statistically significant. The statistical analy-
sis was performed using the Statistical Package for Social 
Sciences (SPSS) 14.0.
RESULTS
Initially, 55 patients with CD were assessed. Two (3.7%) 
patients did not meet the inclusion criteria and were ex-
cluded from the initial interview. Fifty-three (96.3%) pa-
tients were, therefore, included (33 females and 20 males, 
mean age 40.6 ± 11.8 years, ranging from 18 to 65 years). 
Over follow-up, three (5.7%) patients were lost and con-
sequently excluded from the study. Thus, a total of 50 
subjects participated in the entire period of study.
Table 1 shows the main socioeconomic and clinical 
characteristics of the participants at baseline.
The mean CD duration was 78 months; most patients 
(86%) had the inflammatory phenotype of the disease, 
with 41 (82%) patients in clinical remission and 18 (36%) 
having already undergone some surgical procedure to 
treat CD complications.
As for the initial psychological assessment, 14 (28%) 
patients were observed to have baseline depressive mood; 
28 (56%) had anxiety symptoms. Mood swings were 
found in 29 (58%) patients assessed throughout follow-
up. Out of these, 14 (28%) subjects had progression of 
depression and/or anxiety symptoms compared with 
the baseline normal mood, while 15 (30%) had a mood 
normalization from baseline depressive and/or anxious 
mood during the follow-up.
Table 2 shows the association between mood swings 
and sociodemographic and clinical characteristics of pa-
tients with CD. Females and patients who had not un-
dergone a previous surgery from CD complications were 
found to have a significantly higher incidence of mood 
swings (p = 0.04 for both). A trend for an association of 
alcohol intake and higher incidence of mood swings was 
found (p = 0.06), though the number of patients with an 
alcoholic intake in the sample was too low (n = 3) for a 
robust statistical analysis.
During follow-up, no correlation between mood 
swings and change in CD clinical activity was observed 
(p = 0.15). Thus, out of 29 (58%) patients with mood 
swings, 19 (38%) did not show any change in CD clini-
cal activity, while 10 (20%) had a change in CD activity, 
with 5 (10%) showing a flare in a previously remitting 
disease and 5 (10%) having a remission in a previously 
active disease.
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Table 1 – Clinical and sociodemographic features in Crohn’s 
disease (n = 50)
DISCUSSION
Sigmund Freud, in 1886, highlighted the role of psy-
chological suffering in the genesis of organic alterations 
(e.g., diarrhea, constipation, abdominal pain, etc.), in-
fluenced by both conscious and unconscious factors29. 
Subsequently, with the advent of psychoanalysis, the 
unconscious origin of diseases, regression, and gains 
has been consolidated. However, only in the 1930s, with 
psychosomatic therapies based on the study of mind-
body relationships and the importance of the emotional 
origin of organic diseases, IBDs were classified as a psy-
chosomatic etiology, a status they held over many years30. 
In the 1950s, behaviorism was concerned with seeking 
scales and instruments for treatment evaluation, as well 
as specific diagnostic criteria, by dealing with methodol-
ogy, reliability, and validity of diagnoses and studies31.
Currently, the most accepted theory for IBD etiol-
ogy is immune. However, the role of the emotions in the 
immune system is evident15. Stress might be defined as a 
breaking in the natural homeostasis in which the body’s 
normal multisystem response to an insult is exceeded, 
which could trigger, enhance, or maintain the intestinal 
mucosa inflammation32. In addition to the importance of 
stress in the immune theory, Zozaya et al. pointed out the 
importance of a series of factors influencing the individu-
al’s behavior with respect to recovery in chronic illnesses, 
such as the individual’s biological framework, genetics, 
and environmental and psychological factors33. There-
fore, several studies have demonstrated the importance 
of psychological factors in the course of disease, as well as 
in the treatment response of several chronic diseases34-37. 
This has also been approached in several studies evaluat-
ing a correlation between stress and IBD activity. Despite 
conflicting results, many patients assign importance to 
psychological factors, particularly stress, as contributing 
to the disease onset and clinical course18,38.
Despite several studies addressing psychological fac-
tors and their influence on the inflammatory bowel dis-
ease course, North et al.14 highlighted various method-
ological limitations in these studies, such as retrospective 
design, short follow-up, and inclusion of patients hav-
ing CD and ulcerative colitis (URC) in the same study, 
among other flaws39-41. In spite of the methodological 
improvement in subsequent studies, the results remain 
controversial19.
Andrews et al. assessed 162 patients with IBD 
through the HADS and observed an overall preva-
lence of anxiety and/or depression in approximately 
33% of patients. It was found that patients with a more 
severe illness presented a higher incidence of anxiety 
and/or depression symptoms than those clinically well 
Gender
Female (n) (%) 32 (64)
Male (n) (%) 18 (36)
Age (years) (mean ± SD) 40.6 ± 11.8
Race
White (n) (%) 43 (86)
Non-white (n) (%) 7 (14)
Marital status
Married (n) (%) 29 (58)
Single/separated (n) (%) 21 (42)
Occupation
Stable income (n) (%) 36 (72)
No ﬁxed income (n) (%) 14 (28)
Education
Elementary (n) (%) 23 (46)
High school and college (n) (%) 27 (54)
Smoking (n) (%) 4 (8)
Alcohol intake (n) (%) 3 (6)
Disease duration (months)  
(mean ± SD)
78.3 ± 58.7
History of depression in 
the family (n) (%)
23 (46)
Crohn’s disease phenotype
Inﬂammatory (n) (%) 43 (86)
Penetrating (n) (%) 4 (8)
Stenosing (n) (%) 3 (6)
Initial CDAI
Remission (n) (%) 41 (82)
Clinical activity (n) (%) 9 (18)
Previous surgery (n) (%) 18 (36)
BDI
Normal (n) (%) 36 (72)
Depressive mood (n) (%) 14 (28)
Initial HADS
Normal (n) (%) 22 (44)
Anxiety (n) (%) 28 (56)
SD, standard deviation; CDAI, Crohn’s Disease Activity Index; 
BDI, Beck depression inventory; HADS, Subscale of the Hospital 
Anxiety and Depression Scale.
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Table 2 – Relationship between clinical and sociodemographic features and mood swings in patients with Crohn’s disease
Characteristics
Patients with mood 
swings (n = 29)
n (%)





Female – n (%) 22 (44) 10 (20)
Male – n (%) 7 (14) 11 (22)
Age (mean) 21 29 0.24
Marital status 0.21
Stable relationship, n (%) 19 (38) 10 (20)
No steady partner, n (%) 10 (20) 11 (22)
Race 0.38
White – n (%) 26 (52) 17 (34)
Non-white – n (%) 3 (6) 4 (8)
Fixed income 0.57
Yes – n (%) 20 (40) 16 (32)
No – n (%) 9 (18) 5 (10)
Education 0.90
Complete Elementary School (n) 14 9
Complete High School (n) 12 10
University (n) 3 2
Smoking 0.74
Yes – n (%) 2 (4) 2 (4)
No – n (%) 27 (54) 19 (38)
Alcoholism 0.06
Yes – n (%) 3 (6) 0 (0)
No – n (%) 26 (52) 21 (42)
Disease duration (months) 29 21 0.75
Previous surgery resulting from CD 0.04
Yes – n (%) 7 (14) 11 (22)
No – n (%) 22 (44) 10 (20)
Corticosteroid use 0.15
Yes – n (%) 8 (16) 10 (20)
No – n (%) 21 (42) 11 (22)
CD, Crohn’s disease.
(50% versus 8%, p = 0.01)24. Other studies have also doc-
umented a higher incidence of depression and/or anxiety 
symptoms in patients with IBD; this association, to date, 
appears to be more consistent in ulcerative colitis than 
in CD40,42-44.
Goodhand et al. assessed, in a recently published 
cross-sectional study, 204 patients with IBD (103 with 
URC and 101 with CD) and 124 healthy individuals for 
the occurrence of depression or anxiety disorder by us-
ing the HADS. Depression and anxiety were twice as 
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frequent in patients with IBD than in the control group. 
The incidence of mild, moderate, and severe depression 
was 15%, 3%, and 1%, respectively. Anxiety occurred 
more frequently, with an incidence of mild anxiety in 
25%, moderate anxiety in 29%, and severe anxiety in 4%. 
If, on one hand, the occurrence of mood disorders was 
associated with the disease activity in URC cases, the 
same did not occur in patients with CD, which supports 
the data foun d in this study’s population45.
This is the first Brazilian prospective longitudinal 
study assessing the incidence of mood swings in outpa-
tients with CD, as well as the factors that might be associ-
ated with CD.
The present study clearly demonstrates a high inci-
dence (58%) of mood swings in patients with CD com-
pared with a healthy adult population. Andrade et al. 
assessed 1,464 individuals in the catchment area of the 
Clinics Hospital of the Medical School of the Universi-
dade de São Paulo and observed that approximately 45% 
of the assessed population had some kind of mood dis-
order. Major depression was observed in 19% and 13% 
of females and males, respectively. Anxiety diagnosis 
was also more common in females, occurring in 16% of 
cases46. Similar data were also observed by the National 
Comorbidity Survey, a nationwide study assessing 8,098 
adults, a probabilistic sample of the general American 
population47.
Mood swings were practically bidirectional, that is, a 
similar percentage of patients (30%) had their IBD and 
HADS-A scores normalized from baseline depressive 
and/or anxious mood during follow-up, while another 
group (28%) developed depression or anxiety symptoms 
from a baseline normal mood over the study time. Thus, 
a periodic screening of the psychological status appears 
important to detect mood swings over the course of the 
disease, whether CD is active or not.
The incidence of mood swings (58%) observed in the 
present study is quite high compared with the prevalence 
of anxiety and depression (25% to 36%) in other stud-
ies also assessing CD patients40,46,48. The definition used 
in the present study to consider the presence of mood 
swings in CD (i.e., a mood swing was considered when 
patients had a change in their psychological status in at 
least one follow-up visit) perhaps warrants, at least par-
tially, the high mood swing rate observed in this study. 
Also, as a result of the chronic condition experienced by 
these patients, a higher predisposition to psychological 
disorders in this population due to onerous conditions of 
life could be found. It is important to underline that the 
psychometric tests used in this study, such as BDI and 
HADS-A, are appropriate and widely validated methods 
to investigate depression and anxiety symptoms in clini-
cal populations10,18,42.
Interestingly, history of previous surgery was a pro-
tective factor for the occurrence of mood swings. A pos-
sible explanation for this observed association is that 
those patients may have had their fear decreased, as they 
had already undergone a surgical procedure promoting 
short- and medium-term symptomatic relief. Thus, the 
operated patients, following the elimination of physical 
symptoms that were worsening their health status, were 
also expected to show psychological improvement.
Regarding the high mood swing rate in females 
(44% of the patients), there is no scientific explanation 
justifying the fact; however, a number of studies indi-
cate that women are more susceptible to psychological 
disorders46,49-54, which may result from concerns about 
body image, effects of the disease on relationships and 
life, and other factors relating these symptoms to female 
hormones.
It is important to underline that, despite the low rate 
of significant alcohol intake observed in this study, these 
patients were prone to mood swings. This fact is not sur-
prising, as the impact of alcohol abuse on the psyche is 
well known. Of note, during the systematic follow-up of 
the patients, they were instructed on the harm caused by 
alcohol abuse, which warrants the low alcohol intake in 
the study group.
Despite the high incidence of mood swings in the 
study sample, their correlation with a change in the dis-
ease activity could not be proved. The present study dis-
agrees with the results obtained by Houssam et al., who 
observed higher anxiety and hopelessness levels associ-
ated with higher disease activity indices (also assessed by 
the CDAI)55. A higher disease reactivation likelihood fol-
lowing stressful events was also observed in other stud-
ies56. However, these studies were performed in patients 
with ulcerative colitis, which often has a different clinical 
course than CD.
However, a limitation in the current study should be 
reported. Although the patients analyzed attended the 
IBD clinic in this institution, the sample size calculation 
had to be based on their assiduity, considering the study’s 
longitudinal design.
CONCLUSION
Based on the above considerations, the mood swing inci-
dence over the follow-up was observed to be high (58%), 
comprising the majority of the study patients. The disor-
der was predominantly found in females and those not 
undergoing a surgical procedure resulting from CD. In 
spite of the significant incidence of mood swings in the 
MOOD SWINGS IN PATIENTS WITH CROHN’S DISEASE: INCIDENCE AND ASSOCIATED FACTORS
487Rev Assoc Med Bras 2012; 58(4):481-488
study group, no association between this incidence and a 
change in CD activity could be observed.
Periodic psychological assessment may be useful to 
detect and manage mood swings in patients with CD. 
Further studies seeking to make connections between 
psychological and organic features are necessary, in order 
to better know the patient and develop better therapeutic 
strategies to improve quality of life in these patients.
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